BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17005820)

  • 1. Effect of tigecycline on normal oropharyngeal and intestinal microflora.
    Nord CE; Sillerström E; Wahlund E
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3375-80. PubMed ID: 17005820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of ceftaroline on normal human intestinal microflora.
    Panagiotidis G; Bäckström T; Asker-Hagelberg C; Jandourek A; Weintraub A; Nord CE
    Antimicrob Agents Chemother; 2010 May; 54(5):1811-4. PubMed ID: 20231399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of dalbavancin on the normal intestinal microflora.
    Nord CE; Rasmanis G; Wahlund E
    J Antimicrob Chemother; 2006 Sep; 58(3):627-31. PubMed ID: 16840427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ecological impact of doxycycline at low dose on normal oropharyngeal and intestinal microflora.
    Rashid MU; Panagiotidis G; Bäckström T; Weintraub A; Nord CE
    Int J Antimicrob Agents; 2013 Apr; 41(4):352-7. PubMed ID: 23332619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tigecycline: first of a new class of antimicrobial agents.
    Rose WE; Rybak MJ
    Pharmacotherapy; 2006 Aug; 26(8):1099-110. PubMed ID: 16863487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of telavancin on human intestinal microflora.
    Rashid MU; Weintraub A; Nord CE
    Int J Antimicrob Agents; 2011 Dec; 38(6):474-9. PubMed ID: 21982049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ceftobiprole on the normal human intestinal microflora.
    Bäckström T; Panagiotidis G; Beck O; Asker-Hagelberg C; Rashid MU; Weintraub A; Nord CE
    Int J Antimicrob Agents; 2010 Dec; 36(6):537-41. PubMed ID: 20926263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects.
    Muralidharan G; Micalizzi M; Speth J; Raible D; Troy S
    Antimicrob Agents Chemother; 2005 Jan; 49(1):220-9. PubMed ID: 15616299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae.
    Vasilev K; Reshedko G; Orasan R; Sanchez M; Teras J; Babinchak T; Dukart G; Cooper A; Dartois N; Gandjini H; Orrico R; Ellis-Grosse E;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i29-40. PubMed ID: 18684704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum and urine pharmacokinetics of tigecycline in obese class III and normal weight adults.
    Pai MP
    J Antimicrob Chemother; 2014 Jan; 69(1):190-9. PubMed ID: 23883872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tigecycline: a novel glycylcycline antibiotic.
    Zhanel GG; Karlowsky JA; Rubinstein E; Hoban DJ
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):9-25. PubMed ID: 16441206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Susceptibility to tigecycline of isolates from samples collected in hospitalized patients with secondary peritonitis undergoing surgery.
    Tubau F; Liñares J; Rodríguez MD; Cercenado E; Aldea MJ; González-Romo F; Torroba L; Berdonces P; Plazas J; Aguilar L; Delgado A; García-Escribano N;
    Diagn Microbiol Infect Dis; 2010 Mar; 66(3):308-13. PubMed ID: 20022193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cefaclor on the normal human oropharyngeal and intestinal microflora.
    Nord CE; Heimdahl A; Lundberg C; Marklund G
    Scand J Infect Dis; 1987; 19(6):681-5. PubMed ID: 3441750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tigecycline does not induce proliferation or cytotoxin production by epidemic Clostridium difficile strains in a human gut model.
    Baines SD; Saxton K; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2006 Nov; 58(5):1062-5. PubMed ID: 17030519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ecological effects of linezolid versus amoxicillin/clavulanic acid on the normal intestinal microflora.
    Lode H; Von der Höh N; Ziege S; Borner K; Nord CE
    Scand J Infect Dis; 2001; 33(12):899-903. PubMed ID: 11868762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of tigecycline and comparators against organisms associated with intra-abdominal infections collected as part of TEST (2004-2009).
    Mayne D; Dowzicky MJ
    Diagn Microbiol Infect Dis; 2012 Oct; 74(2):151-7. PubMed ID: 22770774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of cefpodoxime proxetil and amoxicillin on the normal oral and intestinal microflora.
    Brismar B; Edlund C; Nord CE
    Eur J Clin Microbiol Infect Dis; 1993 Sep; 12(9):714-9. PubMed ID: 8243490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
    Sader HS; Jones RN; Dowzicky MJ; Fritsche TR
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):203-8. PubMed ID: 16105565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of loracarbef on the normal oropharyngeal and intestinal microflora.
    Nord CE; Grahnen A; Eckernäs SA
    Scand J Infect Dis; 1991; 23(2):255-60. PubMed ID: 1853174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of beta-lactam prodrugs on human intestinal microflora.
    Sjövall J; Huitfeldt B; Magni L; Nord CE
    Scand J Infect Dis Suppl; 1986; 49():73-84. PubMed ID: 3547627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.